Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes
PaperCitations, authors & open-access status
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 86 citations, 2020 year and bronze oa status.
86
Citations
2020
Year
bronze
OA Status